Literature DB >> 20214040

The role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitor.

Amy B Heimberger1, Ling-Yuan Kong, Mohamed Abou-Ghazal, Chantal Reina-Ortiz, David S Yang, Jun Wei, Wei Qiao, Robert J Schmittling, Gary E Archer, John H Sampson, Nobuyoshi Hiraoka, Waldemar Priebe, Gregory N Fuller, Raymond Sawaya.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20214040

Source DB:  PubMed          Journal:  Clin Neurosurg        ISSN： 0069-4827


× No keyword cloud information.
  11 in total

1.  Anti-GITR therapy promotes immunity against malignant glioma in a murine model.

Authors:  Jason Miska; Aida Rashidi; Alan L Chang; Megan E Muroski; Yu Han; Lingjiao Zhang; Maciej S Lesniak
Journal:  Cancer Immunol Immunother       Date:  2016-10-12       Impact factor: 6.968

Review 2.  Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance.

Authors:  T E Taylor; F B Furnari; W K Cavenee
Journal:  Curr Cancer Drug Targets       Date:  2012-03       Impact factor: 3.428

Review 3.  Recent advances and future of immunotherapy for glioblastoma.

Authors:  Neha Kamran; Alexandra Calinescu; Marianela Candolfi; Mayuri Chandran; Yohei Mineharu; Antonela S Asad; Carl Koschmann; Felipe J Nunez; Pedro R Lowenstein; Maria G Castro
Journal:  Expert Opin Biol Ther       Date:  2016-07-27       Impact factor: 4.388

4.  Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11).

Authors:  Sridharan Gururangan; Elizabeth Reap; Robert Schmittling; Mehmet Kocak; Renee Reynolds; Gerald Grant; Arzu Onar-Thomas; Patricia Baxter; Ian F Pollack; Peter Phillips; James Boyett; Maryam Fouladi; Duane Mitchell
Journal:  Cancer Immunol Immunother       Date:  2017-08-20       Impact factor: 6.968

Review 5.  Current state and future prospects of immunotherapy for glioma.

Authors:  Neha Kamran; Mahmoud S Alghamri; Felipe J Nunez; Diana Shah; Antonela S Asad; Marianela Candolfi; David Altshuler; Pedro R Lowenstein; Maria G Castro
Journal:  Immunotherapy       Date:  2018-02-01       Impact factor: 4.196

Review 6.  T-cell Dysfunction in Glioblastoma: Applying a New Framework.

Authors:  Karolina I Woroniecka; Kristen E Rhodin; Pakawat Chongsathidkiet; Kristin A Keith; Peter E Fecci
Journal:  Clin Cancer Res       Date:  2018-03-28       Impact factor: 12.531

7.  Phosphorylation of signal transducer and activator of transcription 3 (STAT3) correlates with Her-2 status, carbonic anhydrase 9 expression and prognosis in esophageal cancer.

Authors:  Sebastian F Schoppmann; Bettina Jesch; Julia Friedrich; Gerd Jomrich; Florian Maroske; Peter Birner
Journal:  Clin Exp Metastasis       Date:  2012-04-08       Impact factor: 5.150

Review 8.  Recent developments on immunotherapy for brain cancer.

Authors:  Derek A Wainwright; Pragati Nigam; Bart Thaci; Mahua Dey; Maciej S Lesniak
Journal:  Expert Opin Emerg Drugs       Date:  2012-04-25       Impact factor: 4.191

9.  Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time.

Authors:  Mi Zhou; Paige M Bracci; Lucie S McCoy; George Hsuang; Joseph L Wiemels; Terri Rice; Shichun Zheng; Karl T Kelsey; Margaret R Wrensch; John K Wiencke
Journal:  Int J Cancer       Date:  2015-02-02       Impact factor: 7.316

Review 10.  The potential origin of glioblastoma initiating cells.

Authors:  David A Chesler; Mitchell S Berger; Alfredo Quinones-Hinojosa
Journal:  Front Biosci (Schol Ed)       Date:  2012-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.